Consideration of the subcutaneously implanted B16 melanoma as a screening model for potential anticancer agents.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001201:Ascites / Q000378:metabolism; D006224:Cricetinae; D005260:Female; D007939:Leukemia L1210 / Q000378:metabolism; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008722:Methods; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D008954:Models, Biological; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000378:metabolism; D013997:Time Factors; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents